As a part of Row for the Cure’s 26th anniversary of campaigning to end breast cancer, all athletes, coaches and supporters are being asked to participate in Pink the Boathouse. Supported by Pocock Racing, Pocock Foundation, Regatta Central, Rowing Blazers, Scull and Sweep, JLRacing and USRowing, anyone can get involved in the efforts by wearing pink to any race or Saturday practice through the month of October.
Additionally, across the nation, organizations are hosting Pink the Boathouse events on October 5 (or wherever one fits in their schedules).
As stated on the Row for the Cure website, “the month-long initiative, which will include tributes to survivors, honoring those lost to breast cancer and recognition of caregivers, is designed to demonstrate the rowing community’s continued support of breast cancer survivors and those still battling and the ongoing effort to end breast cancer. It’s a very simple concept — get your pink on and share stories.”
Get involved on social media and tag #pinktheboathouse!
For more information on Pink the Boathouse, click here or contact Beth Kohl and Eliza Sydney at president@rowforthecure.org and vicepresident@rowforthecure.org.
About Row for the Cure - Row for the Cure (RFTC) is the rowing and water-sports community’s crusade against breast cancer, working with organizations which provide rowing for survivors and raising over $2.7 million to benefit local affiliates of Susan G.Komen through a series of regattas and indoor rowing events across the U.S. Komen works with partners to fund research, community health, global outreach, and public policy initiatives in order to make a major impact against breast cancer.
USRowing is a nonprofit organization recognized by the United States Olympic Committee as the governing body for the sport of rowing in the United States. USRowing has 83,000 individual members and 1,350 member organizations, offering rowing programs for all. USRowing receives generous support from the National Rowing Foundation and its corporate sponsors and partners.
There are no comments
Please login to post comments